speb/financial-data huggingface dataset:
Financial ratios for CNI — quarterly report dated 2025-06-30
Total revenue: 3118248175.1824813
Gross profit: 1333576642.3357663
Operating income: 1195620437.9562042
Net income: 855474452.5547445
Capital expenditures: 587591240.8759123
Operating cash flow: 1273722627.7372262
Depreciation & amortization: 356934306.56934303
Net tangible assets: 15366423357.664232
Owner earnings: 624817518.2481753
Return on net tangible assets (%): 4.06612198365951
Capex to operating income (%): 49.14529914529914
Buffett classification: The Good
Stock price: 102.15
P/E ratio: 37.058847498262686
Shares outstanding: 604900000
Book value: 15719708029.197079
P/B ratio: 3.930768617663448
Market cap (USD): 61790535000
Debt to equity: 0.9636887072808321
Current ratio: 0.817041892277002
Quick ratio: 0.5842120262182958
Effective tax rate (%): 24.91992312620115
Interest coverage ratio: 7.47945205479452
COGS to revenue (%): 57.23314606741573
Free cash flow (dilution-adjusted): 686131386.8613138
Buyback yield (%): 0.3579316528197706
Retained earnings: 14014598540.145985
Inventory turnover: 2.99265605875153
Receivables turnover: 3.777188328912467
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.075074624063679
FCF margin (%): 22.00374531835206
Revenue growth (%): 1.2740152285021207
Rule of 40 score: 23.277760546854182
Financial ratios for CNI — quarterly report dated 2025-09-30
Total revenue: 2996402877.697842
Gross profit: 1271223021.5827339
Operating income: 1155395683.4532375
Net income: 819424460.4316547
Capital expenditures: 794964028.7769785
Operating cash flow: 1376258992.8057554
Depreciation & amortization: 359712230.21582735
Net tangible assets: 14944604316.546764
Owner earnings: 384172661.8705034
Return on net tangible assets (%): 2.570644586723149
Capex to operating income (%): 68.80448318804483
Buffett classification: The Good
Stock price: 93.2
P/E ratio: 22.67048984737441
Shares outstanding: 604900000
Book value: 15304316546.762592
P/B ratio: 3.6837110515677147
Market cap (USD): 56376680000
Debt to equity: 1.0087434776477224
Current ratio: 0.6019650131799664
Quick ratio: 0.41504912532949917
Effective tax rate (%): 24.419376244193764
Interest coverage ratio: 7.07488986784141
COGS to revenue (%): 57.5750300120048
Free cash flow (dilution-adjusted): 581294964.028777
Buyback yield (%): 1.32587093526701
Retained earnings: 13517266187.05036
Inventory turnover: 3.074358974358974
Receivables turnover: 3.3426966292134837
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.002935621996597
FCF margin (%): 19.399759903961584
Revenue growth (%): -3.9074919839409104
Rule of 40 score: 15.492267920020673
Financial ratios for CNI — quarterly report dated 2025-12-31
Total revenue: 3258394160.5839415
Gross profit: 1431386861.3138685
Operating income: 1264963503.6496348
Net income: 910948905.109489
Capital expenditures: 897080291.9708029
Operating cash flow: 1625547445.2554743
Depreciation & amortization: 332846715.32846713
Net tangible assets: 15582481751.824816
Owner earnings: 346715328.4671532
Return on net tangible assets (%): 2.2250327899569045
Capex to operating income (%): 70.91748413156377
Buffett classification: The Good
Stock price: 97.7
P/E ratio: 17.393561835830575
Shares outstanding: 604900000
Book value: 15743065693.430653
P/B ratio: 3.7539530832715147
Market cap (USD): 59098730000
Debt to equity: 1.002874629080119
Current ratio: 0.668560606060606
Quick ratio: 0.4699675324675324
Effective tax rate (%): 25.22468544038346
Interest coverage ratio: 7.405982905982905
COGS to revenue (%): 56.070788530465954
Free cash flow (dilution-adjusted): 728467153.2846714
Buyback yield (%): 0.7546446454261436
Retained earnings: 13808759124.08759
Inventory turnover: 3.41008174386921
Receivables turnover: 3.996418979409132
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.159007637762264
FCF margin (%): 22.356630824372758
Revenue growth (%): 8.743526607723362
Rule of 40 score: 31.10015743209612
Financial ratios for CNI — annual report dated 2025-12-31
Total revenue: 12630656934.306568
Gross profit: 5351824817.518248
Operating income: 4808029197.080292
Net income: 3445255474.4525547
Capital expenditures: 2670072992.70073
Operating cash flow: 5145255474.452555
Depreciation & amortization: 1414598540.1459854
Net tangible assets: 15582481751.824816
Owner earnings: 2189781021.8978105
Return on net tangible assets (%): 14.052838673412033
Capex to operating income (%): 55.53362684074693
Buffett classification: The Good
Stock price: 97.7
P/E ratio: 17.153656800847457
Shares outstanding: 604900000
Book value: 15743065693.430653
P/B ratio: 3.7539530832715147
Market cap (USD): 59098730000
Debt to equity: 1.002874629080119
Current ratio: 0.668560606060606
Quick ratio: 0.4699675324675324
Effective tax rate (%): 24.648786717752234
Interest coverage ratio: 7.214676889375684
COGS to revenue (%): 57.62829403606102
Free cash flow (dilution-adjusted): 2475182481.751825
Buyback yield (%): 2.612231464936651
Retained earnings: 13808759124.08759
Inventory turnover: 13.5858310626703
Receivables turnover: 15.491495076096689
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.007145591425292
FCF margin (%): 19.59662505779011
Revenue growth (%): 5.9594005400586205
Rule of 40 score: 25.55602559784873
Financial ratios for CNRI.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -48494.85294117647
Operating income: -2931591.9117647056
Net income: -2863733.088235294
Capital expenditures: 339540.44117647054
Operating cash flow: -1344980.882352941
Depreciation & amortization: 48494.85294117647
Net tangible assets: 22891812.5
Owner earnings: -3154778.676470588
Return on net tangible assets (%): -13.781253347547679
Buffett classification: The Gruesome
Stock price: 1.8308823529411764
Shares outstanding: 114320317
Book value: 22891812.5
P/B ratio: 9.14331492877382
Market cap (USD): 209307050.97794116
Debt to equity: 0
Current ratio: 3.5121010905412824
Quick ratio: 3.5121010905412824
Free cash flow (dilution-adjusted): -14906190.441176469
Buyback yield (%): 0
Retained earnings: -4674128.676470588
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.806290073207203
Rule of 40 score: 0
Financial ratios for CNRI.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -70396.9696969697
Operating income: -5277137.121212121
Net income: -4848860.6060606055
Capital expenditures: 86415.90909090909
Operating cash flow: -2121574.242424242
Depreciation & amortization: 70396.9696969697
Net tangible assets: 34091250.75757576
Owner earnings: -4864879.545454545
Return on net tangible assets (%): -14.27017031451529
Buffett classification: The Gruesome
Stock price: 1.5075757575757576
Shares outstanding: 114320317
Book value: 34091250.75757576
P/B ratio: 5.055447796067644
Market cap (USD): 172346538.50757575
Debt to equity: 0.042765971389931184
Current ratio: 5.877371788225338
Quick ratio: 5.877371788225338
Interest coverage ratio: -35.097071138139704
Free cash flow (dilution-adjusted): -18967410.606060605
Buyback yield (%): 0
Retained earnings: -9664629.545454545
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.185670764359099
Rule of 40 score: 0
Financial ratios for CNRI.V — quarterly report dated 2024-09-30
Capital expenditures: 2825.9259259259256
Buffett classification: The Gruesome
Stock price: 0.7703703703703704
Shares outstanding: 114320317
Market cap (USD): 88068984.94814815
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNRI.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: 36755.244755244756
Operating income: -234758.04195804195
Net income: -173436.36363636365
Capital expenditures: 0
Operating cash flow: -301141.95804195805
Depreciation & amortization: -36755.244755244756
Net tangible assets: 30318406.993006993
Owner earnings: -210191.6083916084
Return on net tangible assets (%): -0.693280515826869
Buffett classification: The Gruesome
Stock price: 0.7482517482517483
Shares outstanding: 114320317
Book value: 30318406.993006993
P/B ratio: 2.8214007772794307
Market cap (USD): 85540377.05594407
Debt to equity: 0.022237569818994773
Current ratio: 1.980642816094671
Quick ratio: 1.980642816094671
Interest coverage ratio: -11.383269472042317
Free cash flow (dilution-adjusted): -578948.9510489511
Buyback yield (%): 0
Retained earnings: -10239697.202797202
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7282050995051018
Rule of 40 score: 0
Financial ratios for CNRI.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -16932.167832167834
Operating income: -1680504.895104895
Net income: -1321279.7202797204
Capital expenditures: 2667.832167832168
Operating cash flow: -962639.8601398602
Depreciation & amortization: 16932.167832167834
Net tangible assets: 30318406.993006993
Owner earnings: -1307015.3846153847
Return on net tangible assets (%): -4.310963253830753
Buffett classification: The Gruesome
Stock price: 0.7482517482517483
Shares outstanding: 114320317
Book value: 30318406.993006993
P/B ratio: 2.8214007772794307
Market cap (USD): 85540377.05594407
Debt to equity: 0.022237569818994773
Current ratio: 1.980642816094671
Quick ratio: 1.980642816094671
Interest coverage ratio: -15.264798734667691
Free cash flow (dilution-adjusted): -2338223.076923077
Buyback yield (%): 0.10212819041434025
Retained earnings: -10239697.202797202
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.212823484774979
Rule of 40 score: 0
Financial ratios for CNRI.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -4232.8671328671335
Operating income: -208997.2027972028
Net income: 32443.356643356645
Capital expenditures: 179406.2937062937
Operating cash flow: -218557.34265734267
Depreciation & amortization: 4232.8671328671335
Net tangible assets: 30330732.16783217
Owner earnings: -142730.06993006993
Return on net tangible assets (%): -0.4705790455050241
Buffett classification: The Gruesome
Stock price: 0.7132867132867133
P/E ratio: 628.3502356985817
Shares outstanding: 114320317
Book value: 30330732.16783217
P/B ratio: 2.6884666919220406
Market cap (USD): 81543163.17482518
Debt to equity: 0.016698519471134852
Current ratio: 1.2612919494372954
Quick ratio: 1.2612919494372954
Interest coverage ratio: -13.52518441417387
Free cash flow (dilution-adjusted): -406064.33566433564
Buyback yield (%): 0.03717538642570693
Retained earnings: -10207078.321678322
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.654990352750787
Rule of 40 score: 0
Financial ratios for CNRI.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -4418.248175182482
Operating income: -231324.08759124085
Net income: -247651.82481751824
Capital expenditures: 256872.2627737226
Operating cash flow: -12024.087591240876
Depreciation & amortization: 4418.978102189781
Net tangible assets: 31397909.489051092
Owner earnings: -500105.10948905104
Return on net tangible assets (%): -1.5927974748237457
Buffett classification: The Gruesome
Stock price: 0.510948905109489
Shares outstanding: 114320317
Book value: 31397909.48905109
P/B ratio: 1.8603735647842659
Market cap (USD): 58411840.8029197
Debt to equity: 0.011942307935513678
Current ratio: 0.4699743242995304
Quick ratio: 0.4699743242995304
Interest coverage ratio: -19.341714983216356
Free cash flow (dilution-adjusted): -277445.2554744525
Buyback yield (%): 0.04157241296463015
Retained earnings: -10900637.956204379
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6999283052416594
Rule of 40 score: 0
Financial ratios for CNRI.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -4354.676258992806
Operating income: -130041.72661870504
Net income: -111890.64748201439
Capital expenditures: 0
Operating cash flow: -234279.85611510792
Depreciation & amortization: 4354.676258992806
Net tangible assets: 30844971.942446046
Owner earnings: -107535.97122302158
Return on net tangible assets (%): -0.3486337138632321
Buffett classification: The Gruesome
Stock price: 0.5035971223021583
Shares outstanding: 114320317
Book value: 30844971.942446046
P/B ratio: 1.8664754427170025
Market cap (USD): 57571382.6618705
Debt to equity: 0
Current ratio: 0.337088102450858
Quick ratio: 0.337088102450858
Interest coverage ratio: -16.672016233167312
Free cash flow (dilution-adjusted): -69406.47482014389
Buyback yield (%): 0
Retained earnings: -10855685.611510793
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4007816259413323
Rule of 40 score: 0
Financial ratios for COHANCE.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.0249241724911
Shares outstanding: 382597330
Market cap (USD): 3070314561.847554
Buyback yield (%): 0
Retained earnings: 167837082.94870105
Capitalized R&D asset: 1365488.5929051826
Rule of 40 score: 0
Financial ratios for COHANCE.NS — annual report dated 2023-03-31
Total revenue: 162132777.10109624
Gross profit: 90732667.47868454
Operating income: 64104786.8453106
Net income: 50096260.657734476
Capital expenditures: 34816102.314250916
Operating cash flow: 55687673.56881852
Depreciation & amortization: 5844872.107186358
Net tangible assets: 203775152.2533496
Owner earnings: 21125030.450669914
Return on net tangible assets (%): 10.366833353855421
Capex to operating income (%): 54.311236379686655
Buffett classification: The Good
Stock price: 5.753958587088916
P/E ratio: 43.94438154558957
Shares outstanding: 382597330
Book value: 211350097.44214374
P/B ratio: 10.41612575056148
Market cap (USD): 2201449192.350792
Debt to equity: 0.040537941704520956
Current ratio: 6.3681521031909245
Quick ratio: 4.397890227057573
Effective tax rate (%): 26.519849398763473
Interest coverage ratio: 41.0822268536949
COGS to revenue (%): 44.038047641588776
R&D to revenue (%): 0.6450029941174663
SG&A to revenue (%): 2.7471807178083916
Free cash flow (dilution-adjusted): 20862801.46163216
Buyback yield (%): 0
Retained earnings: 178460487.21071866
Inventory turnover: 1.873962310716012
Receivables turnover: 11.998544248972186
Capitalized R&D asset: 1960638.623994341
ROCI (R&D-adjusted, %): 28.977814260368888
FCF margin (%): 12.867725967972147
Rule of 40 score: 12.867725967972147
Financial ratios for COHANCE.NS — annual report dated 2024-03-31
Total revenue: 124002878.04293081
Gross profit: 85886796.97805493
Operating income: 42499100.61158412
Net income: 36009113.80261422
Capital expenditures: 6221369.468761242
Operating cash flow: 46141024.10360955
Depreciation & amortization: 6547547.667586042
Net tangible assets: 238486629.0922173
Owner earnings: 36335292.00143902
Return on net tangible assets (%): 15.235777426913522
Capex to operating income (%): 14.63882618510158
Buffett classification: The Great
Stock price: 8.122600767754319
P/E ratio: 86.30274500599174
Shares outstanding: 382597330
Book value: 245913179.038254
P/B ratio: 12.637327444395831
Market cap (USD): 3107685366.3987527
Debt to equity: 0.03170183403473011
Current ratio: 10.671039182282794
Quick ratio: 8.701703577512777
Effective tax rate (%): 25.979244213276797
Interest coverage ratio: 50.99280575539568
COGS to revenue (%): 30.73806162118252
SG&A to revenue (%): 2.4988878788464888
Free cash flow (dilution-adjusted): 39683415.277611226
Buyback yield (%): 0
Retained earnings: 211670464.0844226
Inventory turnover: 1.3747837370242215
Receivables turnover: 7.736495585814755
Capitalized R&D asset: 1151271.2843797822
ROCI (R&D-adjusted, %): 16.193742102985134
Rosenberg metric: -4.633820982583734
FCF margin (%): 32.00201148869505
Revenue growth (%): -23.517699344895522
Rule of 40 score: 8.484312143799524
Financial ratios for COHANCE.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 203870043.0004778
Buffett classification: The Gruesome
Stock price: 14.010989010989011
Shares outstanding: 382597330
Book value: 242286192.06880075
P/B ratio: 22.124938035022335
Market cap (USD): 5360566986.263737
Debt to equity: 0.019453564843572833
Current ratio: 4.903208196858991
Quick ratio: 3.9983623078861177
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COHANCE.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.27369157244434
Shares outstanding: 382597330
Market cap (USD): 5078478954.860706
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COHANCE.NS — quarterly report dated 2025-03-31
Total revenue: 98248772.50409165
Gross profit: 63175122.74959083
Operating income: 20464110.35772738
Net income: 14078793.546878653
Capital expenditures: 0
Depreciation & amortization: 6332709.843348141
Net tangible assets: 114283376.19826981
Owner earnings: 20411503.390226793
Return on net tangible assets (%): 17.860430859878473
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 13.432139106080056
P/E ratio: 91.25605367148422
Shares outstanding: 382597330
Book value: 215178863.689502
P/B ratio: 23.882924512467063
Market cap (USD): 5139100558.174816
Debt to equity: 0.15161574235048678
Current ratio: 2.4332265396095183
Quick ratio: 1.9771078068950407
Effective tax rate (%): 27.177223845340958
Interest coverage ratio: 16.751196172248804
COGS to revenue (%): 35.69881725803764
Buyback yield (%): 0
Retained earnings: 161793313.0699088
Inventory turnover: 1.8011646755117967
Receivables turnover: 2.9546477288707638
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.56463758550342
Rule of 40 score: 0
Financial ratios for COHANCE.NS — annual report dated 2025-03-31
Total revenue: 304945054.94505495
Gross profit: 209494973.1119944
Operating income: 73680149.63759644
Net income: 56972176.7594108
Capital expenditures: 37018938.50830021
Operating cash flow: 78717559.03670797
Depreciation & amortization: 19499649.286883328
Net tangible assets: 114283376.19826981
Owner earnings: 39452887.537993915
Return on net tangible assets (%): 34.521982855623065
Capex to operating income (%): 50.24275695744613
Buffett classification: The Good
Stock price: 13.432139106080056
P/E ratio: 90.20368977434109
Shares outstanding: 382597330
Book value: 215178863.689502
P/B ratio: 23.882924512467063
Market cap (USD): 5139100558.174816
Debt to equity: 0.15161574235048678
Current ratio: 2.4332265396095183
Quick ratio: 1.9771078068950407
Effective tax rate (%): 24.647153105208282
Interest coverage ratio: 15.34973209936678
COGS to revenue (%): 31.3007475560667
SG&A to revenue (%): 1.7266628330458116
Free cash flow (dilution-adjusted): 39154781.38882394
Buyback yield (%): 0
Retained earnings: 161793313.0699088
Inventory turnover: 4.901722999339617
Receivables turnover: 9.170651103923499
Capitalized R&D asset: 345101.21802679665
ROCI (R&D-adjusted, %): 23.49785979699129
FCF margin (%): 12.839946329308031
Revenue growth (%): 145.91772365112402
Rule of 40 score: 158.75766998043204
Financial ratios for COHANCE.NS — quarterly report dated 2025-06-30
Total revenue: 64276854.66885093
Gross profit: 46942429.20664639
Operating income: 7824713.316171309
Net income: 5712614.088462439
Capital expenditures: 0
Depreciation & amortization: 5282003.276386614
Owner earnings: 10994617.364849053
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.325766440439972
P/E ratio: 218.94390132100662
Shares outstanding: 382597330
Market cap (USD): 4333208000.315937
Effective tax rate (%): 26.06755895474825
Interest coverage ratio: 6.568762278978388
COGS to revenue (%): 26.96837851122317
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -34.57744760508426
Rule of 40 score: -34.57744760508426
Financial ratios for COHANCE.NS — quarterly report dated 2025-09-30
Total revenue: 62634723.7880496
Gross profit: 46723788.04960541
Operating income: 8673055.24239008
Net income: 8351747.463359639
Capital expenditures: 0
Depreciation & amortization: 4962795.941375422
Net tangible assets: 274446448.7034949
Owner earnings: 13314543.404735062
Return on net tangible assets (%): 4.851417632705375
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.910935738444193
P/E ratio: 134.7360499571487
Shares outstanding: 382597330
Book value: 442458850.0563698
P/B ratio: 8.570056968794352
Market cap (USD): 3791897551.3303266
Debt to equity: 0.11485727244235733
Current ratio: 2.9225506034400834
Quick ratio: 1.9835281446989137
Effective tax rate (%): 20.747284230631493
Interest coverage ratio: 8.781963470319635
COGS to revenue (%): 25.402739528772255
Buyback yield (%): 0
Inventory turnover: 0.2380414249089192
Receivables turnover: 0.9421390900303549
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5581990273662125
Revenue growth (%): -2.554777904521699
Rule of 40 score: -2.554777904521699
Financial ratios for COHANCE.NS — quarterly report dated 2025-12-31
Total revenue: 60660577.03018826
Gross profit: 42958672.16219227
Operating income: 5392670.1570680635
Net income: 4090453.3808622034
Capital expenditures: 0
Depreciation & amortization: 5228918.346886488
Owner earnings: 9319371.727748692
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.888381419182355
P/E ratio: 69.89223717937668
Shares outstanding: 382597330
Market cap (USD): 2252879009.00078
Effective tax rate (%): 28.52216748768473
Interest coverage ratio: 5.313940724478596
COGS to revenue (%): 29.181893306399783
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.151840765741504
Rule of 40 score: -3.151840765741504
Financial ratios for CTZ.V — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.6341463414634146
Shares outstanding: 26851932
Market cap (USD): 17028054.43902439
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTZ.V — annual report dated 2022-10-31
Total revenue: 3966750.7352941176
Gross profit: 2313700
Operating income: 1290958.088235294
Net income: 1025323.5294117646
Capital expenditures: 6846.323529411764
Operating cash flow: 707366.1764705882
Depreciation & amortization: 16761.764705882353
Net tangible assets: 4446064.705882353
Owner earnings: 1035238.9705882352
Return on net tangible assets (%): 23.284388309026752
Capex to operating income (%): 0.5303288768088908
Buffett classification: The Great
Stock price: 0.40441176470588236
P/E ratio: 10.591034824015376
Shares outstanding: 26851932
Book value: 4446064.705882353
P/B ratio: 2.4424379590146477
Market cap (USD): 10859237.205882354
Debt to equity: 0
Current ratio: 10.102352102637205
Quick ratio: 10.102352102637205
Effective tax rate (%): 26.557475132749982
Interest coverage ratio: 31921.872727272726
COGS to revenue (%): 41.67266474765148
SG&A to revenue (%): 25.782863104174197
Free cash flow (dilution-adjusted): 700519.8529411764
Buyback yield (%): 0
Retained earnings: 308183.0882352941
Receivables turnover: 5.1932816711590295
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.035971665623663
FCF margin (%): 17.659790082303616
Rule of 40 score: 17.659790082303616
Financial ratios for CTZ.V — annual report dated 2023-10-31
Total revenue: 4415231.884057972
Gross profit: 2646739.1304347827
Operating income: 1543795.652173913
Net income: 1170199.2753623188
Capital expenditures: 3610.144927536232
Operating cash flow: 1202716.6666666667
Depreciation & amortization: 5210.869565217392
Net tangible assets: 5615628.985507247
Owner earnings: 1171800
Return on net tangible assets (%): 20.866763153765472
Capex to operating income (%): 0.2338486264326866
Buffett classification: The Great
Stock price: 0.6014492753623188
P/E ratio: 13.801132322935212
Shares outstanding: 26851932
Book value: 5615628.985507247
P/B ratio: 2.8759156071667475
Market cap (USD): 16150075.043478262
Debt to equity: 0
Current ratio: 10.153579327894974
Quick ratio: 10.153579327894974
Effective tax rate (%): 29.689180351851256
COGS to revenue (%): 40.054357280954264
SG&A to revenue (%): 24.980420218545152
Free cash flow (dilution-adjusted): 1060361.5942028987
Buyback yield (%): 0.46404863566757715
Retained earnings: 1473915.9420289856
Receivables turnover: 5.1583785490721645
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.49105498525853
FCF margin (%): 24.015988787169583
Revenue growth (%): 11.306007830880281
Rule of 40 score: 35.321996618049866
Financial ratios for CTZ.V — annual report dated 2024-10-31
Total revenue: 4920968.345323741
Gross profit: 3071487.769784173
Operating income: 1850372.6618705038
Net income: 1503938.8489208634
Capital expenditures: 5941.726618705036
Operating cash flow: 1804371.223021583
Depreciation & amortization: 5052.517985611511
Net tangible assets: 5945191.366906475
Owner earnings: 1503049.6402877697
Return on net tangible assets (%): 25.281770552490517
Capex to operating income (%): 0.32110972784793884
Buffett classification: The Great
Stock price: 0.6762589928057554
P/E ratio: 12.074201356151114
Shares outstanding: 26851932
Book value: 5945191.366906475
P/B ratio: 3.0543777935036305
Market cap (USD): 18158860.489208635
Debt to equity: 0
Current ratio: 9.451833973559696
Quick ratio: 9.451833973559696
Effective tax rate (%): 27.65140608171526
COGS to revenue (%): 37.58367145964428
SG&A to revenue (%): 24.814528812689083
Free cash flow (dilution-adjusted): 1716289.9280575542
Buyback yield (%): 1.3467234931018919
Retained earnings: 1995684.892086331
Receivables turnover: 7.009696539907278
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.123853677284202
FCF margin (%): 34.87707718519459
Revenue growth (%): 11.454357880767866
Rule of 40 score: 46.33143506596245
Financial ratios for CTZ.V — quarterly report dated 2024-10-31
Total revenue: 1333973.381294964
Gross profit: 833251.0791366907
Operating income: 487476.9784172662
Net income: 402505.035971223
Capital expenditures: 2543.884892086331
Operating cash flow: 417389.20863309357
Depreciation & amortization: 1478.4172661870505
Net tangible assets: 5945191.366906475
Owner earnings: 401439.5683453237
Return on net tangible assets (%): 6.752340565181993
Capex to operating income (%): 0.5218471855523891
Buffett classification: The Great
Stock price: 0.6762589928057554
P/E ratio: 11.278654219438696
Shares outstanding: 26851932
Book value: 5945191.366906475
P/B ratio: 3.0543777935036305
Market cap (USD): 18158860.489208635
Debt to equity: 0
Current ratio: 9.451833973559696
Quick ratio: 9.451833973559696
Effective tax rate (%): 27.72344122415497
COGS to revenue (%): 37.53615395774942
SG&A to revenue (%): 25.92061472649191
Free cash flow (dilution-adjusted): 396855.3956834533
Buyback yield (%): 0.07238276267333746
Retained earnings: 1995684.892086331
Receivables turnover: 1.9001846667185893
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.199517027000601
FCF margin (%): 29.749873666759612
Rule of 40 score: 29.749873666759612
Financial ratios for CTZ.V — quarterly report dated 2025-01-31
Total revenue: 1339043.448275862
Gross profit: 870708.275862069
Operating income: 555182.7586206896
Net income: 484127.5862068966
Capital expenditures: 2757.241379310345
Operating cash flow: 481044.1379310345
Depreciation & amortization: 1175.1724137931035
Net tangible assets: 6195271.0344827585
Owner earnings: 482545.51724137936
Return on net tangible assets (%): 7.788933116171033
Capex to operating income (%): 0.4966367086327585
Buffett classification: The Great
Stock price: 0.6413793103448276
P/E ratio: 8.893458108079233
Shares outstanding: 26851932
Book value: 6195271.0344827585
P/B ratio: 2.7799064046959963
Market cap (USD): 17222273.62758621
Debt to equity: 0
Current ratio: 7.26824551093882
Quick ratio: 7.26824551093882
Effective tax rate (%): 27.012653489847054
COGS to revenue (%): 34.97535296683737
SG&A to revenue (%): 23.563501068441546
Free cash flow (dilution-adjusted): 466326.8965517242
Buyback yield (%): 0
Retained earnings: 2397232.4137931033
Receivables turnover: 1.3371861428333336
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.961395805454728
FCF margin (%): 34.82537457258476
Revenue growth (%): 0.3800725750596396
Rule of 40 score: 35.2054471476444
Financial ratios for CTZ.V — quarterly report dated 2025-04-30
Total revenue: 1456702.8985507248
Gross profit: 959983.3333333334
Operating income: 632264.4927536233
Net income: 403884.7826086957
Capital expenditures: 0
Operating cash flow: 380880.4347826087
Depreciation & amortization: 1264.4927536231885
Net tangible assets: 6920421.7391304355
Owner earnings: 405149.27536231885
Return on net tangible assets (%): 5.854401518211904
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.9565217391304349
P/E ratio: 15.898381049266096
Shares outstanding: 26851932
Book value: 6920421.7391304355
P/B ratio: 3.711400498964313
Market cap (USD): 25684456.69565218
Debt to equity: 0
Current ratio: 8.672443847608964
Quick ratio: 8.672443847608964
Effective tax rate (%): 26.89369594358852
COGS to revenue (%): 34.09889317249098
SG&A to revenue (%): 22.497301330680262
Free cash flow (dilution-adjusted): 373867.39130434784
Buyback yield (%): 0
Retained earnings: 2922715.942028986
Receivables turnover: 1.3563012260517788
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.136213320332534
FCF margin (%): 25.665315259296108
Revenue growth (%): 8.78682842041906
Rule of 40 score: 34.452143679715164
Financial ratios for CTZ.V — annual report dated 2025-10-31
Total revenue: 5636860.714285715
Gross profit: 3627435
Operating income: 2284147.142857143
Net income: 1775792.142857143
Capital expenditures: 6900.714285714286
Operating cash flow: 1568932.142857143
Depreciation & amortization: 5332.142857142858
Net tangible assets: 7705465.714285715
Owner earnings: 1774223.5714285716
Return on net tangible assets (%): 23.025520289308552
Capex to operating income (%): 0.3021133864906126
Buffett classification: The Great
Stock price: 0.8714285714285714
P/E ratio: 13.176959272501728
Shares outstanding: 26851932
Book value: 7705465.714285715
P/B ratio: 3.0367458127125344
Market cap (USD): 23399540.742857143
Debt to equity: 0
Current ratio: 13.683672192311324
Quick ratio: 13.683672192311324
Effective tax rate (%): 26.90713732564765
COGS to revenue (%): 35.647957544758
SG&A to revenue (%): 23.830424862876438
Free cash flow (dilution-adjusted): 1528438.5714285716
Buyback yield (%): 0.1419197572871534
Retained earnings: 3757222.142857143
Receivables turnover: 6.307370209691393
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.64320688134916
FCF margin (%): 27.115067213830397
Revenue growth (%): 14.547794635628284
Rule of 40 score: 41.66286184945868
Financial ratios for CTZ.V — quarterly report dated 2025-10-31
Total revenue: 1445129.285714286
Gross profit: 907438.5714285715
Operating income: 554170.7142857143
Net income: 440515.7142857143
Capital expenditures: 2552.1428571428573
Operating cash flow: 472080.7142857143
Depreciation & amortization: 1562.1428571428573
Net tangible assets: 7705465.714285715
Owner earnings: 439525.7142857143
Return on net tangible assets (%): 5.704077217173857
Capex to operating income (%): 0.4605336932018112
Buffett classification: The Great
Stock price: 0.8714285714285714
P/E ratio: 13.517673627986033
Shares outstanding: 26851932
Book value: 7705465.714285715
P/B ratio: 3.0367458127125344
Market cap (USD): 23399540.742857143
Debt to equity: 0
Current ratio: 13.683672192311324
Quick ratio: 13.683672192311324
Effective tax rate (%): 26.857176742669083
COGS to revenue (%): 37.20710109476117
SG&A to revenue (%): 24.445415412659564
Free cash flow (dilution-adjusted): 462382.1428571429
Buyback yield (%): 0.1419197572871534
Retained earnings: 3757222.142857143
Receivables turnover: 1.617028673915337
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.191917203113338
FCF margin (%): 31.995901503622264
Revenue growth (%): -0.7945074351093506
Rule of 40 score: 31.20139406851291
Financial ratios for CTZ.V — quarterly report dated 2026-01-31
Total revenue: 1580648.148148148
Gross profit: 1011557.037037037
Operating income: 697254.074074074
Net income: 486675.5555555555
Capital expenditures: 1493.3333333333333
Operating cash flow: 846936.2962962963
Depreciation & amortization: 1322.2222222222222
Net tangible assets: 8343016.296296296
Owner earnings: 486504.44444444444
Return on net tangible assets (%): 5.8312776478743995
Capex to operating income (%): 0.21417348264567995
Buffett classification: The Great
Stock price: 0.8148148148148149
P/E ratio: 12.05338703275703
Shares outstanding: 26851932
Book value: 8343016.296296295
P/B ratio: 2.6224750405573194
Market cap (USD): 21879352
Debt to equity: 0
Current ratio: 8.224483671133822
Quick ratio: 8.224483671133822
Effective tax rate (%): 26.690604294937163
Interest coverage ratio: 8.713336233789075
COGS to revenue (%): 36.003655321890925
SG&A to revenue (%): 19.884435592525335
Free cash flow (dilution-adjusted): 841817.7777777778
Buyback yield (%): 0.6717342959293817
Retained earnings: 4383054.074074074
Receivables turnover: 1.4534131327042559
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.357338033531173
FCF margin (%): 53.25775877218675
Revenue growth (%): 9.377628961887591
Rule of 40 score: 62.63538773407434
Financial ratios for CWP.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.977443609022556
Shares outstanding: 85075752
Market cap (USD): 338384006.0751879
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWP.AX — annual report dated 2022-06-30
Total revenue: 229680000
Gross profit: 66482758.62068966
Operating income: 34148275.862068966
Net income: 25784827.586206898
Capital expenditures: 675172.4137931034
Depreciation & amortization: 2113103.4482758623
Net tangible assets: 290498620.6896552
Owner earnings: 27222758.62068966
Return on net tangible assets (%): 9.371045740617204
Capex to operating income (%): 1.9771786327375542
Buffett classification: The Great
Stock price: 2.103448275862069
P/E ratio: 6.940222627581042
Shares outstanding: 85075752
Book value: 290498620.6896552
P/B ratio: 0.6160182221768516
Market cap (USD): 178952443.86206895
Debt to equity: 0.48148605370551933
Current ratio: 1.4662590993602873
Quick ratio: 0.13068414584186808
Effective tax rate (%): 30.267084452402266
Interest coverage ratio: 122.25925925925927
COGS to revenue (%): 71.05418032885333
SG&A to revenue (%): 7.283596968495898
Free cash flow (dilution-adjusted): -46088275.862068966
Buyback yield (%): 0
Retained earnings: 194534482.7586207
Inventory turnover: 1.1166868797455511
Receivables turnover: 43.251428571428576
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.971273471910981
FCF margin (%): -20.066299138831837
Rule of 40 score: -20.066299138831837
Financial ratios for CWP.AX — annual report dated 2023-06-30
Total revenue: 259141059.602649
Gross profit: 64400000
Operating income: 30448344.370860927
Net income: 20950331.125827815
Capital expenditures: 1174834.4370860928
Depreciation & amortization: 1755629.1390728478
Net tangible assets: 285498013.2450331
Owner earnings: 21531125.827814568
Return on net tangible assets (%): 7.541602683355679
Capex to operating income (%): 3.858450964612741
Buffett classification: The Great
Stock price: 2.940397350993378
P/E ratio: 11.940456421052632
Shares outstanding: 85075752
Book value: 285498013.2450331
P/B ratio: 0.8762110565017098
Market cap (USD): 250156515.81456956
Debt to equity: 0.4750592667164616
Current ratio: 1.8379667927203973
Quick ratio: 0.3975714961002129
Effective tax rate (%): 30.297889216939144
Interest coverage ratio: 10.687354718735472
COGS to revenue (%): 75.14866995652984
SG&A to revenue (%): 6.8532569389961235
Free cash flow (dilution-adjusted): 14521854.304635761
Buyback yield (%): 0
Retained earnings: 193089403.97350994
Inventory turnover: 1.5078556851162457
Receivables turnover: 81.4196837286725
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.095150353546109
FCF margin (%): 5.603841524343029
Revenue growth (%): 12.827002613483543
Rule of 40 score: 18.430844137826572
Financial ratios for CWP.AX — annual report dated 2024-06-30
Total revenue: 257565333.33333334
Gross profit: 63809333.333333336
Operating income: 29833333.333333332
Net income: 26996000
Capital expenditures: 1137333.3333333333
Depreciation & amortization: 1435333.3333333333
Net tangible assets: 307194000
Owner earnings: 27294000
Return on net tangible assets (%): 8.88493915896795
Capex to operating income (%): 3.812290502793296
Buffett classification: The Great
Stock price: 2.873333333333333
P/E ratio: 9.05508201511335
Shares outstanding: 85075752
Book value: 307194000
P/B ratio: 0.7957544551000344
Market cap (USD): 244450994.07999998
Debt to equity: 0.3137322560553483
Current ratio: 2.3113054695958657
Quick ratio: 0.2695021846132582
Effective tax rate (%): 29.07734342160572
Interest coverage ratio: 4.088624942896299
COGS to revenue (%): 75.22596208599501
SG&A to revenue (%): 7.090757555364593
Free cash flow (dilution-adjusted): 19658000
Buyback yield (%): 0
Retained earnings: 213208000
Inventory turnover: 1.0930117110815263
Receivables turnover: 98.73447482749809
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.295842755431938
FCF margin (%): 7.6322382929379735
Revenue growth (%): -0.6080573536790279
Rule of 40 score: 7.024180939258946
Financial ratios for CYD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.1
Shares outstanding: 37518322
Market cap (USD): 491490018.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYD — annual report dated 2022-12-31
Total revenue: 11963161194.02985
Gross profit: 1621624626.8656716
Operating income: 279746268.6567164
Net income: 250493283.58208954
Capital expenditures: 309364925.3731343
Operating cash flow: -89118656.71641791
Depreciation & amortization: 466188059.7014925
Net tangible assets: 5323971641.791044
Owner earnings: 407316417.91044766
Return on net tangible assets (%): 7.6506120865328615
Capex to operating income (%): 110.58768606946595
Buffett classification: The Gruesome
Stock price: 6.51
P/E ratio: 0.9750531939510398
Shares outstanding: 37518322
Book value: 8832137313.432835
P/B ratio: 0.027654039736058886
Market cap (USD): 244244276.22
Debt to equity: 0.20287790585669838
Current ratio: 1.5232928109257249
Quick ratio: 1.0818529467844917
Effective tax rate (%): 14.963544332017653
Interest coverage ratio: 4.123464123464124
COGS to revenue (%): 86.44484847637986
R&D to revenue (%): 5.217746819277788
SG&A to revenue (%): 7.19874121026764
Free cash flow (dilution-adjusted): -534826865.67164177
Buyback yield (%): 0
Retained earnings: 4971092537.313433
Inventory turnover: 2.797004116488864
Receivables turnover: 2.217396368151207
Capitalized R&D asset: 624207462.6865671
ROCI (R&D-adjusted, %): 6.781428421339599
FCF margin (%): -4.470614890139106
Rule of 40 score: -4.470614890139106
Financial ratios for CYD — annual report dated 2023-12-31
Total revenue: 13671476515.151514
Gross profit: 1926873484.8484848
Operating income: 281113636.3636364
Net income: 320345454.5454545
Capital expenditures: 179696212.12121212
Operating cash flow: 928816666.6666666
Depreciation & amortization: 503837121.2121212
Net tangible assets: 5511662878.787879
Owner earnings: 644486363.6363636
Return on net tangible assets (%): 11.693138310703405
Capex to operating income (%): 63.92297949174011
Buffett classification: The Good
Stock price: 7.91
P/E ratio: 0.9264059246324992
Shares outstanding: 37518322
Book value: 9223958333.333332
P/B ratio: 0.03217381478703558
Market cap (USD): 296769927.02
Debt to equity: 0.21268518043221601
Current ratio: 1.5892295628126092
Quick ratio: 1.2023051300725076
Effective tax rate (%): 25.99028269788151
Interest coverage ratio: 3.882013244478852
COGS to revenue (%): 85.9058860049753
R&D to revenue (%): 4.857370319060104
SG&A to revenue (%): 8.310866646766058
Free cash flow (dilution-adjusted): 620155303.030303
Buyback yield (%): 0
Retained earnings: 5167087121.212121
Inventory turnover: 3.3226904084222078
Receivables turnover: 2.153220395850328
Capitalized R&D asset: 1082293242.4242423
ROCI (R&D-adjusted, %): 4.5003914097698425
Rosenberg metric: 0.48901827714303947
FCF margin (%): 4.536125284953759
Revenue growth (%): 14.279798570081873
Rule of 40 score: 18.81592385503563
Financial ratios for CYD — annual report dated 2024-12-31
Total revenue: 14068805147.058823
Gross profit: 2072427205.8823528
Operating income: 345196323.52941173
Net income: 361575000
Capital expenditures: 264770588.2352941
Operating cash flow: 573100000
Depreciation & amortization: 525610294.117647
Net tangible assets: 5324831617.6470585
Owner earnings: 622414705.8823528
Return on net tangible assets (%): 11.688908693743558
Capex to operating income (%): 76.70145079419854
Buffett classification: The Gruesome
Stock price: 9.31
P/E ratio: 0.9660390730000691
Shares outstanding: 37518322
Book value: 9043797794.117647
P/B ratio: 0.038622665584937356
Market cap (USD): 349295577.82
Debt to equity: 0.20919691062244883
Current ratio: 1.5510542492520125
Quick ratio: 1.1979931227114913
Effective tax rate (%): 20.7557933412834
Interest coverage ratio: 6.340806872053918
COGS to revenue (%): 85.26934459451513
R&D to revenue (%): 5.146236393355659
SG&A to revenue (%): 9.473012753758772
Free cash flow (dilution-adjusted): 166434558.82352942
Buyback yield (%): 60.112791819430015
Retained earnings: 5132160294.117646
Inventory turnover: 3.4927115799722426
Receivables turnover: 2.0655976218434406
Capitalized R&D asset: 1374932175.6990447
ROCI (R&D-adjusted, %): 3.454249597686259
Rosenberg metric: 0.21918290416221473
FCF margin (%): 1.1830042216365735
Revenue growth (%): 2.9062598430167084
Rule of 40 score: 4.089264064653282
Financial ratios for CYD — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 5324831617.6470585
Buffett classification: The Gruesome
Stock price: 9.31
Shares outstanding: 37518322
Book value: 9043797794.117647
P/B ratio: 0.038622665584937356
Market cap (USD): 349295577.82
Debt to equity: 0.20919691062244883
Current ratio: 1.5510542492520125
Quick ratio: 1.1979931227114913
Buyback yield (%): 0
Retained earnings: 5132160294.117646
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYD — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 7346239843.75
Buffett classification: The Gruesome
Stock price: 23.91
Shares outstanding: 37518322
Market cap (USD): 897063079.02
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DMAC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.73
Shares outstanding: 53883345
Market cap (USD): 200984876.85
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DMAC — annual report dated 2022-12-31
Total revenue: 0
Operating income: -14001000
Net income: -13676000
Capital expenditures: 81000
Operating cash flow: -11511000
Depreciation & amortization: 25000
Net tangible assets: 31827000
Owner earnings: -13732000
Return on net tangible assets (%): -43.14575674741572
Buffett classification: The Gruesome
Stock price: 1.58
Shares outstanding: 53883345
Book value: 31827000
P/B ratio: 2.674951616551984
Market cap (USD): 85135685.10000001
Debt to equity: 0.01473591604612436
Current ratio: 15.606549815498155
Quick ratio: 15.606549815498155
Free cash flow (dilution-adjusted): -13094000
Buyback yield (%): 0
Retained earnings: -96177000
Receivables turnover: 0
Capitalized R&D asset: 7839000
ROCI (R&D-adjusted, %): -21.90136275146009
Rule of 40 score: 0
Financial ratios for DMAC — annual report dated 2023-12-31
Total revenue: 0
Operating income: -21267000
Net income: -19381000
Capital expenditures: 24000
Operating cash flow: -18728000
Depreciation & amortization: 30000
Net tangible assets: 51057000
Owner earnings: -19375000
Return on net tangible assets (%): -37.947783849423196
Buffett classification: The Gruesome
Stock price: 2.84
Shares outstanding: 53883345
Book value: 51057000
P/B ratio: 2.997212914977378
Market cap (USD): 153028699.79999998
Debt to equity: 0.007834381181816402
Current ratio: 19.26597272074659
Quick ratio: 19.26597272074659
Free cash flow (dilution-adjusted): -20435000
Buyback yield (%): 0
Retained earnings: -115558000
Receivables turnover: 0
Capitalized R&D asset: 18362130
ROCI (R&D-adjusted, %): -21.7104103712093
Rule of 40 score: 0
Financial ratios for DMAC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.19
Shares outstanding: 53883345
Market cap (USD): 225771215.55
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DMAC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.43
Shares outstanding: 53883345
Market cap (USD): 292586563.34999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DMAC — annual report dated 2024-12-31
Total revenue: 0
Operating income: -26681000
Net income: -24444000
Capital expenditures: 25000
Operating cash flow: -22076000
Depreciation & amortization: 39000
Net tangible assets: 40718000
Owner earnings: -24430000
Return on net tangible assets (%): -59.998035266958105
Buffett classification: The Gruesome
Stock price: 5.43
Shares outstanding: 53883345
Book value: 40718000
P/B ratio: 7.185681107863844
Market cap (USD): 292586563.34999996
Debt to equity: 0.008350115428066211
Current ratio: 8.276437847866418
Quick ratio: 8.276437847866418
Free cash flow (dilution-adjusted): -24186000
Buyback yield (%): 0
Retained earnings: -140002000
Receivables turnover: 0
Capitalized R&D asset: 30427570
ROCI (R&D-adjusted, %): -29.361976366686342
Rule of 40 score: 0
Financial ratios for DMAC — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -8144000
Net income: -7707000
Capital expenditures: 12000
Operating cash flow: -7149000
Depreciation & amortization: 11000
Net tangible assets: 33954000
Owner earnings: -7708000
Return on net tangible assets (%): -22.701301761206338
Buffett classification: The Gruesome
Stock price: 3.79
Shares outstanding: 53883345
Book value: 33954000
P/B ratio: 6.0145454894857755
Market cap (USD): 204217877.55
Debt to equity: 0.00930670907698651
Current ratio: 8.021864951768489
Quick ratio: 8.021864951768489
Free cash flow (dilution-adjusted): -8028000
Buyback yield (%): 0
Retained earnings: -147709000
Receivables turnover: 0
Capitalized R&D asset: 5656000
ROCI (R&D-adjusted, %): -10.982479931024667
Rule of 40 score: 0
Financial ratios for DMAC — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -8007000
Net income: -7699000
Capital expenditures: 6000
Operating cash flow: -7598000
Depreciation & amortization: 3000
Net tangible assets: 27170000
Owner earnings: -7702000
Return on net tangible assets (%): -28.34744203165256
Buffett classification: The Gruesome
Stock price: 3.9
Shares outstanding: 53883345
Book value: 27170000
P/B ratio: 7.734451435406697
Market cap (USD): 210145045.5
Debt to equity: 0.010747147589252852
Current ratio: 7.550777453838679
Quick ratio: 7.550777453838679
Free cash flow (dilution-adjusted): -8375000
Buyback yield (%): 0
Retained earnings: -155408000
Receivables turnover: 0
Capitalized R&D asset: 9611520
ROCI (R&D-adjusted, %): -16.261099532753768
Rule of 40 score: 0
Financial ratios for DMAC — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -9033000
Net income: -8620000
Capital expenditures: 16000
Operating cash flow: -6550000
Depreciation & amortization: 18000
Net tangible assets: 51622000
Owner earnings: -8618000
Return on net tangible assets (%): -16.694432606253148
Buffett classification: The Gruesome
Stock price: 6.87
Shares outstanding: 53883345
Book value: 51622000
P/B ratio: 7.1709461111541595
Market cap (USD): 370178580.15
Debt to equity: 0.0051528418116307
Current ratio: 10.67255125284738
Quick ratio: 10.67255125284738
Free cash flow (dilution-adjusted): -7582000
Buyback yield (%): 0
Retained earnings: -164028000
Receivables turnover: 0
Capitalized R&D asset: 12204220
ROCI (R&D-adjusted, %): -13.39048998575981
Rule of 40 score: 0
Financial ratios for DMAC — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -9213000
Net income: -8740000
Capital expenditures: 6000
Operating cash flow: -7765000
Depreciation & amortization: 11000
Net tangible assets: 56111000
Owner earnings: -8735000
Return on net tangible assets (%): -15.567357559123879
Buffett classification: The Gruesome
Stock price: 7.96
Shares outstanding: 53883345
Book value: 56111000
P/B ratio: 7.643981148081481
Market cap (USD): 428911426.2
Debt to equity: 0.004277236192546916
Current ratio: 11.813912704598597
Quick ratio: 11.813912704598597
Free cash flow (dilution-adjusted): -8963000
Buyback yield (%): 0
Retained earnings: -172768000
Receivables turnover: 0
Capitalized R&D asset: 12933050
ROCI (R&D-adjusted, %): -12.770090424287458
Rule of 40 score: 0